Recent Finacing
Recent Raise
Hera Biotech offers MetriDx, an in‑office non‑surgical endometrial sampling and microfluidic single‑cell test to diagnose and stage endometriosis, marketed as an LDT to OB/GYN and fertility clinics.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Hera Biotech.
